Forbes -- Like the balky human hearts its pacemakers regulate, results at Medtronic (MDT) sometimes skip a beat, but the medical device giant is now so over-sold that it deserves a look by long term-minded investors.
Forbes -- Like the balky human hearts its pacemakers regulate, results at Medtronic (MDT) sometimes skip a beat, but the medical device giant is now so over-sold that it deserves a look by long term-minded investors.
